PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.230
+0.040 (0.95%)
Mar 9, 2026, 1:31 PM EDT - Market open
PolyPid Employees
As of December 31, 2025, PolyPid had 73 total employees, including 69 full-time and 4 part-time employees. The number of employees increased by 13 or 21.67% compared to the previous year.
Employees
73
Change (1Y)
13
Growth (1Y)
21.67%
Revenue / Employee
n/a
Profits / Employee
-$468,068
Market Cap
80.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pliant Therapeutics | 171 |
| Adicet Bio | 152 |
| Seres Therapeutics | 103 |
| Verrica Pharmaceuticals | 71 |
| aTyr Pharma | 65 |
| Pyxis Oncology | 44 |
| AN2 Therapeutics | 22 |
PYPD News
- 12 days ago - PolyPid Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026 - GlobeNewsWire
- 2 months ago - PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors - GlobeNewsWire
- 3 months ago - PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript - Seeking Alpha
- 3 months ago - PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission - GlobeNewsWire
- 3 months ago - PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025 - GlobeNewsWire